Cargando…
Investigation of anti-NMDA receptor antibodies in first episode psychosis patients
INTRODUCTION: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune limbic encephalitis, where psychiatric symptoms are often the initial presentation dominant initially. These patients are mainly admitted to psychiatric wards, due to first episode psychosis (FEP). OBJECTIVES...
Autores principales: | Zsigmond, R.I., Herman, L., Réthelyi, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563515/ http://dx.doi.org/10.1192/j.eurpsy.2022.929 |
Ejemplares similares
-
S10. SCREENING FOR ANTI-NMDAR ANTIBODIES AMONGST PATIENTS WITH FIRST EPISODE PSYCHOSIS
por: Herman, Levente, et al.
Publicado: (2020) -
Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia
por: Masopust, Jiří, et al.
Publicado: (2015) -
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis
por: Pollak, Thomas A., et al.
Publicado: (2021) -
Changes in the practice of electroconvulsive therapy at Semmelweis University before and during the COVID-19 pandemic
por: Herman, L., et al.
Publicado: (2022) -
Anti-NMDA receptor encephalitis and psychosis: case report and literature review
por: Gutierrez Higueras, T., et al.
Publicado: (2022)